Summit Creek Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,935
| Closed | -$320K | – | 73 |
|
|
2023
Q1 | $320K | Sell |
2,935
-1,381
| -32% | -$151K | 0.04% | 64 |
|
|
2022
Q4 | $491K | Sell |
4,316
-801
| -16% | -$91.2K | 0.07% | 57 |
|
|
2022
Q3 | $317K | Sell |
5,117
-3,677
| -42% | -$228K | 0.04% | 61 |
|
|
2022
Q2 | $701K | Sell |
8,794
-1,818
| -17% | -$145K | 0.09% | 59 |
|
|
2022
Q1 | $1.12M | Buy |
10,612
+1,099
| +12% | +$116K | 0.13% | 53 |
|
|
2021
Q4 | $1.03M | Buy |
9,513
+19
| +0.2% | +$2.05K | 0.1% | 61 |
|
|
2021
Q3 | $1.04M | Buy |
9,494
+4,140
| +77% | +$454K | 0.11% | 59 |
|
|
2021
Q2 | $501K | Buy |
5,354
+2,100
| +65% | +$197K | 0.06% | 61 |
|
|
2021
Q1 | $299K | Buy |
+3,254
| New | +$299K | 0.04% | 65 |
|
|
2020
Q4 | – | Sell |
-3,240
| Closed | -$252K | – | 72 |
|
|
2020
Q3 | $252K | Buy |
+3,240
| New | +$252K | 0.04% | 71 |
|